Hi, Continue visiting your profile
user

Login

Email

Password

Create account
Forget password
AnyGenes
  • email login

Wnt beta catenin signaling pathway – Mechanisms, Diseases and Biomarkers

What is the TGF beta signaling pathway

The Wnt beta Catenin signaling pathway (also referred to as  Wnt/β-Catenin signaling pathway) is a highly conserved molecular signaling cascade that regulates cell proliferation, differentiation, migration, and survival.

It plays a fundamental role in embryonic development, tissue homeostasis, and regeneration, and remains tightly controlled in adult tissues.

In the canonical Wnt pathway, extracellular Wnt ligands trigger intracellular signaling events that stabilize β-catenin, allowing it to translocate into the nucleus and activate transcriptional programs controlling cell fate and metabolism.
Dysregulation of Wnt/β-catenin signaling is strongly associated with cancer, fibrosis, metabolic disorders, and stem cell dysfunction.

AnyGenes Wnt/β-Catenin signaling pathway qPCR array for precise gene expression analysis.

Wnt/β-catenin pathway activity can be efficiently assessed by measuring gene expression of core regulators, downstream targets, and pathway-specific biomarker signatures.

Wnt/β-catenin signaling pathway biomarker list
View the genes included in our TGF-β pathway qPCR arrays.

Illustration of Wnt/β-catenin signaling pathway in cell signaling
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.

Key takeaways

  • Master regulator of cell fate, proliferation and differentiation
  • Central pathway in embryogenesis and adult tissue homeostasis
  • Frequently dysregulated in cancer and fibrosis
  • Strongly linked to stem cell maintenance and metabolic regulation
  • Highly suitable for biomarker discovery and gene expression profiling

Core mechanisms of Wnt/β-catenin signaling

Canonical Wnt signaling is initiated when Wnt ligands bind to Frizzled receptors and co-receptors LRP5/6 at the cell surface. This interaction inhibits the β-catenin destruction complex, allowing β-catenin accumulation in the cytoplasm.

Once stabilized, β-catenin translocates to the nucleus, where it interacts with TCF/LEF transcription factors to activate genes involved in:

  • Cell cycle progression
  • Cell survival
  • Tissue maintenance
  • Metabolic adaptation

Core molecular components

Wnt ligands – extracellular signaling proteins
Frizzled receptors & LRP5/6 – signal reception at the membrane
β-catenin – central transcriptional effector
Destruction complex (APC, AXIN, GSK-3β, CK1) – regulates β-catenin degradation in the absence of Wnt signaling

Dynamic regulation of Wnt/β-catenin signaling

The pathway operates through a tightly regulated ON / OFF switch:

OFF state
β-catenin is continuously phosphorylated and degraded by the destruction complex, preventing transcriptional activation.

ON state
Wnt ligand binding inactivates the destruction complex, allowing β-catenin stabilization and nuclear signaling.

This dynamic balance ensures accurate cellular responses to environmental and developmental cues.

Wnt/β-catenin signaling pathway in disease

Aberrant activation or suppression of Wnt/β-catenin signaling contributes to numerous pathological conditions:

Cancer: Hyperactivation promotes uncontrolled proliferation, tumor initiation, progression, and therapeutic resistance
(Common in colorectal, breast, pancreatic and liver cancers).

Fibrosis: Sustained signaling drives fibroblast activation and extracellular matrix deposition

Bone disorders: Impaired signaling alters bone remodeling and density, contributing to osteoporosis.

Neurological diseases: Dysregulation affects neurogenesis and synaptic plasticity, linked to neurodegenerative disorders.

Metabolic diseases: Altered Wnt/β-catenin activity disrupts adipogenesis, glucose metabolism and energy balance.

Crosstalk with other signaling pathways

The Wnt/β-catenin signaling pathway interacts extensively with other major signaling networks:

  • Wnt & TGF-β/SMAD – fibrosis and cancer progression
  • Wnt & PI3K/AKT – cell survival and metabolic regulation
  • Wnt & Notch – stem cell maintenance and differentiation
  • Wnt & Hedgehog – embryonic development and organogenesis

This crosstalk highlights the pathway’s central role in complex biological systems.

Why study the Wnt/β-catenin signaling pathway with AnyGenes®?

At AnyGenes®, we provide high-performance qPCR arrays and customizable SignArrays® dedicated to Wnt/β-catenin pathway analysis.

Our solutions enable researchers to:

  • Quantify Wnt/β-catenin-dependent gene expression signatures
  • Monitor β-catenin target genes and regulatory components
  • Study pathway interactions with TGF-β, PI3K/AKT and Notch signaling
  • Generate robust, reproducible, publication-ready data

Wnt/β-catenin signaling pathway biomarker analysis with AnyGenes®

What can be analyzed?

  • Wnt ligands and Frizzled receptors
  • β-catenin and destruction complex components
  • TCF/LEF transcriptional targets
  • Stem cell, proliferation and metabolic gene signatures
Aberrant Wnt/β-catenin signaling in cancer cells
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.

Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at [email protected] to get started on your project.

Frequently asked questions

It is activated by Wnt ligands binding to Frizzled and LRP5/6 receptors, leading to β-catenin stabilization and nuclear transcriptional activation.

Its dysregulation promotes uncontrolled proliferation, stemness, metastasis and therapy resistance.

Key genes include CTNNB1 (β-catenin), APC, AXIN1/2, GSK3B, LRP5/6, TCF7 and LEF1.

By measuring expression of pathway regulators and downstream targets using targeted gene expression approaches such as qPCR pathway arrays.

  1. Haseeb M et al. Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics. Cells. (2019)3;8(11).
  2. Lecarpentier Y et al. Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers. Front Oncol. (2019)18;9:1248.
  3. Zhong Z et Virshup DM. Wnt signaling and drug resistance in cancer. Mol Pharmacol. (2019)1.
  4.  Mo Y et al. The role of Wnt signaling pathway in tumor metabolic reprogramming. J Cancer. (2019)9;10(16):3789-3797.
  5. Ram Makena M et al. Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance. Int J Mol Sci. (2019)30;20(17).
  6. Ng LF et al. WNT Signaling in Disease. Cells. (2019)3;8(8).

WNT beta catenin signaling pathway biomarker list

You can check the biomarker list included in this pathway, see below:

Looking for more answers? Visit our Help & FAQ section to find detailed informations about our products, services, and technical support.

For more information on prices, please contact us at: